Nitroscanate
Chemical compound
- QP52AX01 (WHO)
- 1-(4-Isothiocyanatophenoxy)-4-nitrobenzene
- 19881-18-6
- 61821
- P4IE5B6D6U
- D05193
Y
- DTXSID9048772
- Interactive image
- C1=CC(=CC=C1N=C=S)OC2=CC=C(C=C2)[N+](=O)[O-]
InChI
- InChI=1S/C13H8N2O3S/c16-15(17)11-3-7-13(8-4-11)18-12-5-1-10(2-6-12)14-9-19/h1-8H
- Key:SVMGVZLUIWGYPH-UHFFFAOYSA-N
Nitroscanate (trade name Lopatol) is an anthelmintic drug used in veterinary medicine to treat Toxocara canis, Toxascaris leonina, Ancylostoma caninum, Uncinaria stenocephala, Taenia, and Dipylidium caninum (roundworms, hookworms and tapeworms).[1][2]
References
- ^ "Lopatol (package insert)". Elanco. Retrieved 29 October 2020.
- ^ Craig TM, Mercer SH, Wade CG, Lynn RC (April 1991). "Efficacy of nitroscanate against naturally acquired infection with Ancylostoma caninum, Dipylidium caninum, and Trichuris vulpis in dogs". American Journal of Veterinary Research. 52 (4): 574–5. PMID 2053726.
- v
- t
- e
| Antitrematodals (schistosomicides) |
| ||||||
|---|---|---|---|---|---|---|---|
| Anticestodals (taeniacides) |
|
(including
macrofilaricides)
| Binds tubulin | |
|---|---|
| Glutamate-gated chloride channel, GABA receptor | |
| NMDA |
|
| Other/unknown |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
